Document is current

Article History

Received: 4 July 2023

Accepted: 10 September 2023

First Online: 2 October 2023

Declarations

:

: Jordan NASRI, Intasar AL ASHIMI, Thibault TRICARD, Raphael FLEURY, Imad MATTA, Elsa BEY, Benoit MESNARD, Sarah GAILLET, Claire MARTIN, Xavier GAME, Gilles KARSENTY, Amélie DEMEESTERE, Véronique PHE, and Patrick VERMERSCH declare that they have no conflict of interest. Caroline THUILLIER received support from Coloplast, Hollister, B Braun, Medtronic, Abbvie, and Stimuli technology. Emmanuel CHARTIER-KASTLER received support from Boston Scientific, Medtronic, Coloplast, Convatec, BBraun, Uromems, and TBF (Tissue Bank of France). Marie-Aimée PERROUIN-VERBE received support from Medtronic, Abbvie, Ipsen, and Uromedica. Laurent WAGNER received support from Coloplast, Neomedic, and ABMedica. Alain RUFFION, Christian SAUSSINE, and Stefan DE WACHTER received support from Medtronic. Benoit PEYRONNET: Medtronic, Boston Scientific, Ipsen, IBSA, Pierre Fabre, Intuitive, Schwa-Medico, Abbvie. Xavier BIARDEAU received support from Medtronic, Ipsen, Abbvie, Coloplast, Hollister, BD, and Convatec.

: In France, clinical retrospective studies focusing on human participants require a commitment to comply to the reference methodology MR-004 through a declaration to the French Advisory Committee on Information Processing in Material Research in the Field of Health (Commission Nationale Informatique et Liberté – CNIL) through the Data Protection Officer (DPO) of the promoting center. The reference methodology MR-004 provides a framework for the processing of personal data for the purposes of studies relating to the re-use of data. The present retrospective study has therefore been declared to the DPO of Lille University Hospital under the reference DEC21-242.

: In France, retrospective clinical studies involving human participants require the sponsor to disseminate information to patients whose data will be used in this study, and to give patients the opportunity to object to the use of their data. Thus, in this retrospective study, all patients whose data were to be reused were sent an information note and an objection document.